{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:31:30Z","timestamp":1783960290182,"version":"3.55.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.gtc.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:55:37Z","timestamp":1695804937000},"page":"733-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Management of Monogenic and Syndromic Obesity"],"prefix":"10.1016","volume":"52","author":[{"given":"Joan C.","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus C.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison R.","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Haqq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6636","key":"10.1016\/j.gtc.2023.08.005_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gtc.2023.08.005_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T\u00a0cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.gtc.2023.08.005_bib3","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1210\/jc.2015-2263","article-title":"Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin Gene","volume":"100","author":"Wabitsch","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/EJE-16-0821","article-title":"Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency","volume":"176","author":"Wabitsch","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.gtc.2023.08.005_bib5","first-page":"1066","article-title":"A\u00a0longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.gtc.2023.08.005_bib6","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1210\/jcem.86.7.7644","article-title":"Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans","volume":"86","author":"Mantzoros","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.gtc.2023.08.005_bib7","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.gtc.2023.08.005_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6674","key":"10.1016\/j.gtc.2023.08.005_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A\u00a0mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Clement","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa063988","article-title":"Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor","volume":"356","author":"Farooqi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"issue":"1\u20132","key":"10.1016\/j.gtc.2023.08.005_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ymgme.2013.04.005","article-title":"Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency","volume":"110","author":"Frank","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"21","key":"10.1016\/j.gtc.2023.08.005_bib13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199511233332104","article-title":"Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function","volume":"333","author":"O'Rahilly","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways","volume":"360","author":"Greenfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.gtc.2023.08.005_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.gtc.2023.08.005_bib17","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Clement","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib19","doi-asserted-by":"crossref","first-page":"bvac057","DOI":"10.1210\/jendso\/bvac057","article-title":"Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide","volume":"6","author":"Wabitsch","year":"2022","journal-title":"J\u00a0Endocr Soc"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000516282","article-title":"A\u00a0Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin Pathway","volume":"34","author":"Kanti","year":"2021","journal-title":"Skin Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib21","doi-asserted-by":"crossref","first-page":"e0131417","DOI":"10.1371\/journal.pone.0131417","article-title":"Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism","volume":"10","author":"Alsters","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib22","first-page":"215","article-title":"Mutations in melanocortin-4 receptor: From fish to men","volume":"189","author":"Tao","year":"2022","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12881-018-0654-1","article-title":"Heterozygous versus homozygous phenotype caused by the same MC4R mutation: novel mutation affecting a large consanguineous kindred","volume":"19","author":"Drabkin","year":"2018","journal-title":"BMC Med Genet"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/genes13122267","article-title":"Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions","volume":"13","author":"Salazar-Valencia","year":"2022","journal-title":"Genes"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12050430","article-title":"The Obesogenic and Glycemic Effect of Bariatric Surgery in a Family with a Melanocortin 4 Receptor Loss-of-Function Mutation","volume":"12","author":"Grinbaum","year":"2022","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11695-021-05869-x","article-title":"Long-Term Weight Outcome After Bariatric Surgery in Patients with Melanocortin-4 Receptor Gene Variants: a Case-Control Study of 105 Patients","volume":"32","author":"Cooiman","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.gtc.2023.08.005_bib28","doi-asserted-by":"crossref","first-page":"792354","DOI":"10.3389\/fendo.2021.792354","article-title":"Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency","volume":"12","author":"Fojas","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/oby.23385","article-title":"Critical review of bariatric surgical outcomes in patients with Prader-Willi syndrome and other hyperphagic disorders","volume":"30","author":"Gantz","year":"2022","journal-title":"Obesity"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib30","doi-asserted-by":"crossref","first-page":"108862","DOI":"10.1016\/j.celrep.2021.108862","article-title":"Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation","volume":"34","author":"Brouwers","year":"2021","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.gtc.2023.08.005_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/life12111793","article-title":"Evaluation of Pharmacological Rescue of Melanocortin-4 Receptor Nonsense Mutations by Aminoglycoside","volume":"12","author":"Hopfner","year":"2022","journal-title":"Life"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib32","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/j.2047-6310.2013.00182.x","article-title":"Hyperphagia among patients with Bardet-Biedl syndrome","volume":"8","author":"Sherafat-Kazemzadeh","year":"2013","journal-title":"Pediatr Obes"},{"issue":"7","key":"10.1016\/j.gtc.2023.08.005_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00467-007-0435-0","article-title":"Bardet-Biedl syndrome: beyond the cilium","volume":"22","author":"Tobin","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.ejhg.5201933","article-title":"Alstrom syndrome","volume":"15","author":"Marshall","year":"2007","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13023-020-01468-8","article-title":"Consensus clinical management guidelines for Alstrom syndrome","volume":"15","author":"Tahani","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib36","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1210\/jc.2010-2290","article-title":"Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance","volume":"96","author":"Feuillan","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.gtc.2023.08.005_bib37","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1210\/jc.2018-00496","article-title":"Comprehensive Endocrine-Metabolic Evaluation of Patients With Alstrom Syndrome Compared With BMI-Matched Controls","volume":"103","author":"Han","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib38","doi-asserted-by":"crossref","first-page":"e1005890","DOI":"10.1371\/journal.pgen.1005890","article-title":"The BBSome Controls Energy Homeostasis by Mediating the Transport of the Leptin Receptor to the Plasma Membrane","volume":"12","author":"Guo","year":"2016","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dneu.22031","article-title":"A\u00a0truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice","volume":"73","author":"Heydet","year":"2013","journal-title":"Dev Neurobiol"},{"issue":"4","key":"10.1016\/j.gtc.2023.08.005_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1017\/S0007114516002282","article-title":"The cilium: a cellular antenna with an influence on obesity risk","volume":"116","author":"Mariman","year":"2016","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/j.gtc.2023.08.005_bib41","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/dom.14133","article-title":"Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome","volume":"22","author":"Haws","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","article-title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrom syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","volume":"10","author":"Haqq","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.gtc.2023.08.005_bib43","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.conctc.2021.100780","article-title":"The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstrom syndrome: Phase 3 trial design","volume":"22","author":"Haws","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.gtc.2023.08.005_bib44","unstructured":"Haqq AM, Chung W, Hu S, et\u00a0al. Clinical Benefit of Setmelanotide in Patients With Alstr\u00f6m Syndrome. Abstracts from the 40th Annual Meeting of the Obesity Society (Poster 218). presented at: ObesityWeek; November 1\u20134, 2022 2022; San Diego, CA."},{"issue":"8","key":"10.1016\/j.gtc.2023.08.005_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146287","article-title":"Bardet-Biedl syndrome proteins regulate intracellular signaling and neuronal function in patient-specific iPSC-derived neurons","volume":"131","author":"Wang","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.gtc.2023.08.005_bib46","unstructured":"Paisey RB, Steeds R, Barrett T, et al. Alstr\u00f6m Syndrome, In: Adam MP, Ardinger HH and Pagon RA. GeneReviews\u00ae [Internet], 2019 (last updated), University of Washington, Seattle; 2003 (initial posting). Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1267\/."},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11695-009-9915-6","article-title":"Roux-en-Y gastric bypass in an adolescent patient with Bardet-Biedl syndrome, a monogenic obesity disorder","volume":"20","author":"Daskalakis","year":"2010","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.gtc.2023.08.005_bib48","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s11695-014-1379-7","article-title":"Adjustable gastric banding and sleeve gastrectomy in Bardet-Biedl syndrome","volume":"24","author":"Mujahid","year":"2014","journal-title":"Obes Surg"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2008.165","article-title":"Prader-Willi syndrome","volume":"17","author":"Cassidy","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib50","first-page":"347","article-title":"Effectiveness of a transdisciplinary approach on hyperphagia management among patients with Prader Willi syndrome","volume":"70","author":"Pedemonti","year":"2023","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)."},{"issue":"4","key":"10.1016\/j.gtc.2023.08.005_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2023.08.005_bib52","first-page":"S1","article-title":"Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia","volume":"22","author":"Heymsfield","year":"2014","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajmg.a.31507","article-title":"Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects","volume":"143A","author":"Butler","year":"2007","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib54","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1067\/S0022-3476(03)00386-X","article-title":"Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome","volume":"143","author":"Bekx","year":"2003","journal-title":"J\u00a0Pediatr. Sep"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0026-0495(98)90003-8","article-title":"Energy expenditure and body composition in Prader-Willi syndrome","volume":"37","author":"Schoeller","year":"1988","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.gtc.2023.08.005_bib56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-8223(21)00737-9","article-title":"A\u00a0nutrition survey of and recommendations for individuals with Prader-Willi syndrome who live in group homes","volume":"92","author":"Hoffman","year":"1992","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"10","key":"10.1016\/j.gtc.2023.08.005_bib57","first-page":"1063","article-title":"Food and children with Prader-Willi syndrome","volume":"130","author":"Holm","year":"1976","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.gtc.2023.08.005_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eatbeh.2016.03.008","article-title":"Nutritional intervention with hypocaloric diet for weight control in children and adolescents with Prader-Willi Syndrome","volume":"21","author":"Lima","year":"2016","journal-title":"Eat Behav"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-277X.2012.01275.x","article-title":"A\u00a0reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome","volume":"26","author":"Miller","year":"2013","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"4","key":"10.1016\/j.gtc.2023.08.005_bib60","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/cen.13933","article-title":"Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome","volume":"90","author":"Irizarry","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.gtc.2023.08.005_bib61","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ebiom.2015.07.007","article-title":"Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children","volume":"2","author":"Zhang","year":"2015","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2788.2009.01169.x","article-title":"Water intake and risk of hyponatraemia in Prader-Willi syndrome","volume":"53","author":"Akefeldt","year":"2009","journal-title":"J\u00a0Intellect Disabil Res"},{"issue":"10","key":"10.1016\/j.gtc.2023.08.005_bib63","doi-asserted-by":"crossref","first-page":"e12535","DOI":"10.1111\/ijpo.12535","article-title":"Consumption of low-calorie sweetened beverages is associated with higher total energy and sugar intake among children, NHANES 2011-2016","volume":"14","author":"Sylvetsky","year":"2019","journal-title":"Pediatr Obes"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/1028415X.2019.1639306","article-title":"Brain activity and connectivity changes in response to nutritive natural sugars, non-nutritive natural sugar replacements and artificial sweeteners","volume":"24","author":"Van Opstal","year":"2021","journal-title":"Nutr Neurosci"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib65","doi-asserted-by":"crossref","first-page":"e1535","DOI":"10.1002\/mgg3.1535","article-title":"Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial","volume":"8","author":"Alyousif","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib66","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s12602-021-09800-9","article-title":"The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial","volume":"13","author":"Kong","year":"2021","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4274\/jcrpe.1228","article-title":"Prader-Willi syndrome and growth hormone deficiency","volume":"6","author":"Aycan","year":"2014","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.gtc.2023.08.005_bib68","unstructured":"Edge R, la Fleur P, Adcock L. Human Growth Hormone Treatment for Children with Prader-Willi Syndrome: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. 2018. Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid response reports."},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12020-020-02547-3","article-title":"Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials","volume":"71","author":"Luo","year":"2021","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.gtc.2023.08.005_bib70","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cen.14372","article-title":"The use of growth hormone therapy in adults with Prader-Willi syndrome: A systematic review","volume":"94","author":"Frixou","year":"2021","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.gtc.2023.08.005_bib71","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/clinem\/dgab406","article-title":"Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis","volume":"106","author":"Rosenberg","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13633-020-00090-6","article-title":"Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program(R) and NordiNet(R) International Outcome Study","volume":"2020","author":"Angulo","year":"2020","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yapd.2016.04.005","article-title":"Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy","volume":"63","author":"Irizarry","year":"2016","journal-title":"Adv Pediatr"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib74","article-title":"Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome","volume":"10","author":"Sjostrom","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cen.14583","article-title":"The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review","volume":"96","author":"Ng","year":"2022","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgac549","article-title":"Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity","volume":"108","author":"Diene","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2021.12.005","article-title":"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1\/GIP\/GCG receptor triagonist","volume":"34","author":"Bossart","year":"2022","journal-title":"Cell Metab"},{"issue":"19","key":"10.1016\/j.gtc.2023.08.005_bib78","first-page":"10","article-title":"Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search","author":"Goldman","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"17","key":"10.1016\/j.gtc.2023.08.005_bib79","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/bph.13540","article-title":"Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist","volume":"173","author":"Bischof","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.yhbeh.2012.02.019","article-title":"Editorial comment: oxytocin, vasopressin and social behavior","volume":"61","author":"Young","year":"2012","journal-title":"Horm Behav"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib81","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/YCO.0000000000000391","article-title":"A\u00a0review of clinical trials of oxytocin in Prader-Willi syndrome","volume":"31","author":"Rice","year":"2018","journal-title":"Curr Opin Psychiatry"},{"issue":"9","key":"10.1016\/j.gtc.2023.08.005_bib83","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ajmg.a.36653","article-title":"A\u00a0double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome","volume":"164A","author":"Einfeld","year":"2014","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib84","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/cen.13169","article-title":"Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial","volume":"85","author":"Kuppens","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib85","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.gtc.2023.08.005_bib86","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2976","article-title":"The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader-Willi Syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.gtc.2023.08.005_bib87","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cen.14387","article-title":"Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3\u00a0months of oxytocin","volume":"94","author":"Damen","year":"2021","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.gtc.2023.08.005_bib88","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jpsychires.2020.11.006","article-title":"Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial","volume":"137","author":"Hollander","year":"2021","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.gtc.2023.08.005_bib89","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad015","article-title":"Intranasal Carbetocin Reduces Hyperphagia, Anxiousness and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial","author":"Roof","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","article-title":"Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome","volume":"50","author":"Kuppens","year":"2015","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib91","doi-asserted-by":"crossref","first-page":"e0190849","DOI":"10.1371\/journal.pone.0190849","article-title":"AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial","volume":"13","author":"Allas","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.gtc.2023.08.005_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032150","article-title":"Clinical Trials in Prader-Willi Syndrome: A Review","volume":"24","author":"Mahmoud","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gtc.2023.08.005_bib93","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac105","article-title":"The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome","author":"Miller","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.gtc.2023.08.005_bib94","doi-asserted-by":"crossref","first-page":"e0221615","DOI":"10.1371\/journal.pone.0221615","article-title":"A\u00a0randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome","volume":"14","author":"Kimonis","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.gtc.2023.08.005_bib95","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","article-title":"Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial","volume":"108","author":"Miller","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.gtc.2023.08.005_bib96","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/oby.2012.87","article-title":"The angiogenic inhibitor TNP-470 decreases caloric intake and weight gain in high-fat fed mice","volume":"20","author":"White","year":"2012","journal-title":"Obesity"},{"issue":"16","key":"10.1016\/j.gtc.2023.08.005_bib97","doi-asserted-by":"crossref","first-page":"10730","DOI":"10.1073\/pnas.162349799","article-title":"Adipose tissue mass can be regulated through the vasculature","volume":"99","author":"Rupnick","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib98","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.RES.0000132745.76882.70","article-title":"Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice","volume":"94","author":"Brakenhielm","year":"2004","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib99","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gtc.2023.08.005_bib100","unstructured":"Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome. Press Release on March 3, 2021. Available at: https:\/\/www.globenewswire.com\/news-release\/2021\/03\/03\/2186073\/0\/en\/Saniona-Receives-U-S-FDA-Orphan-Drug-Designation-for-Tesomet-in-Prader-Willi-Syndrome.html Accessed September 22, 2023."},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib101","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-21-0972","article-title":"Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity","volume":"186","author":"Huynh","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12020-022-03064-1","article-title":"Intensive management of obesity in people with Prader-Willi syndrome","volume":"77","author":"Nolan","year":"2022","journal-title":"Endocrine"},{"issue":"12","key":"10.1016\/j.gtc.2023.08.005_bib103","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.molmet.2016.10.004","article-title":"Targeting the endocannabinoid\/CB1 receptor system for treating obesity in Prader-Willi syndrome","volume":"5","author":"Knani","year":"2016","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.gtc.2023.08.005_bib104","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmg.2010.09.015","article-title":"Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome","volume":"54","author":"Motaghedi","year":"2011","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.gtc.2023.08.005_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.soard.2023.01.017","article-title":"Metabolic and bariatric surgery for obesity in Prader Willi syndrome: systematic review and meta-analysis","author":"Wolfe","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.gtc.2023.08.005_bib106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.omtm.2022.09.012","article-title":"Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the Magel2-null mouse model of Prader-Willi syndrome","volume":"27","author":"Queen","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6","key":"10.1016\/j.gtc.2023.08.005_bib107","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/obr.12531","article-title":"A\u00a0systematic review of genetic syndromes with obesity","volume":"18","author":"Kaur","year":"2017","journal-title":"Obes Rev"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855323000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855323000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:46Z","timestamp":1760179306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855323000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0889855323000833"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2023.08.005","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Monogenic and Syndromic Obesity","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}